This is the authors' abstract. We don't add key points for this paper.
ABSTRACT 5′ nicotinamide adenine dinucleotide (NAD + ) caps are one of the most common metabolites derived non-canonical caps reported on bacterial RNAs. Multiple decapping proteins are known to regulate the stability of NAD + capped transcripts. However, no other proteins have been identified that preferentially interact with these NAD + caps, and mechanistic details of the cap-dependent recognition remain poorly understood. Using an affinity capture approach, we identified multiple E. coli proteins that selectively recognize NAD + caps, including the ATP-dependent RNA helicase, CsdA. CsdA preferentially interacts directly with NAD + capped RNAs and can discriminate between 5′ NAD + capped and 5′ triphosphate end transcripts. Binding to NAD + capped RNA versus 5′ triphosphate RNA more greatly enhances the ATPase activity of CsdA and the presence of NAD + caps on transcripts modulates the ability of CsdA to form RNA condensates. Furthermore, we find that CsdA enhances the decapping activity of the NADH hydrolase NudC, suggesting CsdA plays a role in regulating the degradation of NAD + capped transcripts. CsdA is the first identified NAD + cap reader protein and its preference for binding NAD + capped RNA provides a mechanism by which E. coli cells link RNA stability to the identity of the 5′ cap.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Das et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: